跳至主要内容
临床试验/NCT07722156
NCT07722156尚未招募不适用

The Effect of Channa Striata and Curcuma Supplementation on Nutritional Status, Interleukin-6 Levels, and Quality of Life in Patients With Breast Cancer.

DINA KEUMALA SARI1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2026年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
76
试验地点
1
主要终点
Nutritional status

研究概览

简要总结

Breast cancer is frequently accompanied by chronic inflammation, malnutrition, and reduced quality of life, all of which may compromise treatment response and clinical outcomes. Nutritional interventions with immunomodulatory and anti-inflammatory properties have the potential to improve these conditions. Channa striata is rich in high-quality protein, albumin, and essential amino acids that support nutritional recovery and tissue repair, while Curcuma contains curcumin, a bioactive compound with well-established anti-inflammatory and antioxidant effects. This study aims to evaluate the effect of combined Channa striata and Curcuma supplementation on nutritional status, serum interleukin-6 (IL-6) levels, and quality of life in patients with breast cancer undergoing treatment. The findings are expected to provide evidence for the use of this nutritional supplementation as a complementary strategy to improve clinical outcomes, reduce systemic inflammation, and enhance the overall well-being of breast cancer patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Female patients with breast cancer aged ≥18 years who were undergoing chemotherapy.
  • Patients with a body mass index (BMI) of 18-29 kg/m².
  • Patients currently receiving chemotherapy for breast cancer.
  • Patients with serum albumin levels of 2.0-3.5 g/dL.
  • Patients who were able to consume oral food and were willing to participate in the study by providing written informed consent.

排除标准

  • Patients with chronic kidney disease, renal failure, or kidney infection.
  • Patients with a known allergy to fish or Channa striata (snakehead fish) albumin-derived products.
  • Patients receiving other protein or amino acid supplements during the study period.
  • Patients who were non-compliant or discontinued the intervention before completion of the study.

研究组 & 干预措施

experimental : channa striata and curcuma

Experimental

intervention group

干预措施: channa striata and curcuma (Dietary Supplement)

control

Placebo Comparator

control group

干预措施: Maltodextrin (Placebo) (Dietary Supplement)

结局指标

主要结局

Nutritional status

时间窗: baseline post intervention 4 weeks

This study evaluated changes in BMI, following one month of Channa striata and Curcuma supplementation.

次要结局

  • interleukin - 6(Baseline and 1 month after intervention)

研究者

发起方
DINA KEUMALA SARI
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

DINA KEUMALA SARI

Prof

Universitas Sumatera Utara

研究点 (1)

Loading locations...

相似试验